Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplemental Figure S1 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma
  1. Home
  2. Publications
  3. Supplemental Figure S1 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma

Supplemental Figure S1 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma

Authors:
  • VCVictor J. Collins
    Victor J. Collins
  • KLKatelyn R. Ludwig
    Katelyn R. Ludwig
  • ANAriana E. Nelson
    Ariana E. Nelson
  • SRSoumya Sundara Rajan
    Soumya Sundara Rajan
  • CYChoh Yeung
    Choh Yeung
  • KVKsenia Vulikh
    Ksenia Vulikh
  • KIKristine A. Isanogle
    Kristine A. Isanogle
  • AMArnulfo Mendoza
    Arnulfo Mendoza
  • SDSimone Difilippantonio
    Simone Difilippantonio
  • BKBaktiar O. Karim
    Baktiar O. Karim
  • NCNatasha J. Caplen
    Natasha J. Caplen
  • CHChristine M. Heske
    Christine M. Heske

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.32711218
Abstract
A screen of multiple drug combinations demonstrates the selectivity of the synergistic activity of the DNA-PK clinical inhibitor M3814
Keywords
  • DNA DAMAGE AND REPAIR
  • PEDIATRIC CANCERS
  • SARCOMAS
  • SMALL MOLECULE AGENTS
  • DNA-REACTIVE AGENTS
  • TOPOISOMERASE AGENTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.